Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 3278 entries
Sorted by: Best Match Show Resources per page
Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparity

Minority STEM training

Ko K, Shimada A.
GSID: laGVgvp8hcAJ
J Lombardo, K Ko, A Shimada, N Nelson… - Cancer Causes & …, 2022 - Springer

… In part, this may stem from gaps in health literacy; for instance, not all patients are aware that … Formal training for health care providers was thought to be more significantly prudent by …

Cite
Lombardo, J., Ko, K., Shimada, A., Nelson, N., Wright, C., Chen, J., ... & Simone, N. L. (2022). Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparity. Cancer Causes & Control, 33(4), 559-582.
Lombardo, Joseph, et al. "Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparity." Cancer Causes & Control 33.4 (2022): 559-582.
Copy Download .nbib Format: MLA
[Down's syndrome. 1. Clinical presentation].

Sanfujinka no jissai. Practice of gynecology and obstetrics

Shimada N.
PMID: 5107653
Sanfujinka No Jissai. 1971 Jan;20(1):87-94.

No abstract available.

Cite
Shimada N. [Down's syndrome. 1. Clinical presentation]. Sanfujinka No Jissai. 1971;20(1):87-94
Shimada, N. (1971). [Down's syndrome. 1. Clinical presentation]. Sanfujinka no jissai. Practice of gynecology and obstetrics, 20(1), 87-94.
Shimada, N. "[Down's syndrome. 1. Clinical presentation]." Sanfujinka no jissai. Practice of gynecology and obstetrics vol. 20,1 (1971): 87-94.
Shimada N. [Down's syndrome. 1. Clinical presentation]. Sanfujinka No Jissai. 1971 Jan;20(1):87-94. Japanese. PMID: 5107653.
Copy Download .nbib Format: NLM
Rod and ring chromosome cross-overs described by braid group.

Journal of theoretical biology

Shikata M.
PMID: 5964705
J Theor Biol. 1966 Feb;10(2):184-95. doi: 10.1016/0022-5193(66)90122-6.

No abstract available.

Cite
Shikata M. Rod and ring chromosome cross-overs described by braid group. J Theor Biol. 1966;10(2):184-95doi: 10.1016/0022-5193(66)90122-6.
Shikata, M. (1966). Rod and ring chromosome cross-overs described by braid group. Journal of theoretical biology, 10(2), 184-95. https://doi.org/10.1016/0022-5193(66)90122-6
Shikata, M. "Rod and ring chromosome cross-overs described by braid group." Journal of theoretical biology vol. 10,2 (1966): 184-95. doi: https://doi.org/10.1016/0022-5193(66)90122-6
Shikata M. Rod and ring chromosome cross-overs described by braid group. J Theor Biol. 1966 Feb;10(2):184-95. doi: 10.1016/0022-5193(66)90122-6. PMID: 5964705.
Copy Download .nbib Format: NLM
[Caries detection in mass screening examination].

Nihon Shika Ishikai zasshi

Shimada Y.
PMID: 5271730
Nihon Shika Ishikai Zasshi. 1970 May;23(2):123-30.

No abstract available.

Cite
Shimada Y. [Caries detection in mass screening examination]. Nihon Shika Ishikai Zasshi. 1970;23(2):123-30
Shimada, Y. (1970). [Caries detection in mass screening examination]. Nihon Shika Ishikai zasshi, 23(2), 123-30.
Shimada, Y. "[Caries detection in mass screening examination]." Nihon Shika Ishikai zasshi vol. 23,2 (1970): 123-30.
Shimada Y. [Caries detection in mass screening examination]. Nihon Shika Ishikai Zasshi. 1970 May;23(2):123-30. Japanese. PMID: 5271730.
Copy Download .nbib Format: NLM
Massive deposition and accumulation of hydroxyapatite crystal after total hip arthroplasty: a case report.

Case reports in orthopedics

Yamada S, Nozaka K, Saito H, Kijima H, Tazawa H, Takasaki Y, Shimada Y.
PMID: 23476851
Case Rep Orthop. 2013;2013:305180. doi: 10.1155/2013/305180. Epub 2013 Feb 07.

We presented a case in which massive hydroxyapatite accumulation was observed around the artificial hip joint. A 66-year-old female showed a massive accumulation of fluid in and around the hip joint, and milk-like aspirate was obtained. Her aspirate culture...

Cite
Yamada S, Nozaka K, Saito H, et al. Massive deposition and accumulation of hydroxyapatite crystal after total hip arthroplasty: a case report. Case Rep Orthop. 2013;2013:305180doi: 10.1155/2013/305180.
Yamada, S., Nozaka, K., Saito, H., Kijima, H., Tazawa, H., Takasaki, Y., & Shimada, Y. (2013). Massive deposition and accumulation of hydroxyapatite crystal after total hip arthroplasty: a case report. Case reports in orthopedics, 2013305180. https://doi.org/10.1155/2013/305180
Yamada, Shin, et al. "Massive deposition and accumulation of hydroxyapatite crystal after total hip arthroplasty: a case report." Case reports in orthopedics vol. 2013 (2013): 305180. doi: https://doi.org/10.1155/2013/305180
Yamada S, Nozaka K, Saito H, Kijima H, Tazawa H, Takasaki Y, Shimada Y. Massive deposition and accumulation of hydroxyapatite crystal after total hip arthroplasty: a case report. Case Rep Orthop. 2013;2013:305180. doi: 10.1155/2013/305180. Epub 2013 Feb 07. PMID: 23476851; PMCID: PMC3580907.
Copy Download .nbib Format: NLM
Asymmetric Nazarov Cyclizations.

Tetrahedron

Shimada N, Stewart C, Tius MA.
PMID: 21857751
Tetrahedron. 2011 Aug 19;67(33):5851-5870. doi: 10.1016/j.tet.2011.05.062.

No abstract available.

Cite
Shimada N, Stewart C, Tius MA. Asymmetric Nazarov Cyclizations. Tetrahedron. 2011;67(33):5851-5870doi: 10.1016/j.tet.2011.05.062.
Shimada, N., Stewart, C., & Tius, M. A. (2011). Asymmetric Nazarov Cyclizations. Tetrahedron, 67(33), 5851-5870. https://doi.org/10.1016/j.tet.2011.05.062
Shimada, Naoyuki, et al. "Asymmetric Nazarov Cyclizations." Tetrahedron vol. 67,33 (2011): 5851-5870. doi: https://doi.org/10.1016/j.tet.2011.05.062
Shimada N, Stewart C, Tius MA. Asymmetric Nazarov Cyclizations. Tetrahedron. 2011 Aug 19;67(33):5851-5870. doi: 10.1016/j.tet.2011.05.062. PMID: 21857751; PMCID: PMC3156462.
Copy Download .nbib Format: NLM
Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in rats.

Experimental and therapeutic medicine

Takeuchi K, Shibata M, Kashiyama E, Umehara K.
PMID: 23181130
Exp Ther Med. 2012 Sep;4(3):524-532. doi: 10.3892/etm.2012.627. Epub 2012 Jun 29.

In the development of anti-blood cancer drugs, the chronic myelocytic leukemia (KU812), acute myelocytic leukemia (KG-1) and lymphoma (U937) cell lines are commonly used in preclinical pharmacology studies as human cancer xenograft models in mice. In the present study,...

Cite
Takeuchi K, Shibata M, Kashiyama E, et al. Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in rats. Exp Ther Med. 2012;4(3):524-532doi: 10.3892/etm.2012.627.
Takeuchi, K., Shibata, M., Kashiyama, E., & Umehara, K. (2012). Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in rats. Experimental and therapeutic medicine, 4(3), 524-532. https://doi.org/10.3892/etm.2012.627
Takeuchi, Kenji, et al. "Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in rats." Experimental and therapeutic medicine vol. 4,3 (2012): 524-532. doi: https://doi.org/10.3892/etm.2012.627
Takeuchi K, Shibata M, Kashiyama E, Umehara K. Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in rats. Exp Ther Med. 2012 Sep;4(3):524-532. doi: 10.3892/etm.2012.627. Epub 2012 Jun 29. PMID: 23181130; PMCID: PMC3503844.
Copy Download .nbib Format: NLM
Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse.

Molecular neurodegeneration

Takamura A, Okamoto Y, Kawarabayashi T, Yokoseki T, Shibata M, Mouri A, Nabeshima T, Sun H, Abe K, Urisu T, Yamamoto N, Shoji M, Yanagisawa K, Michikawa M, Matsubara E.
PMID: 21375782
Mol Neurodegener. 2011 Mar 06;6(1):20. doi: 10.1186/1750-1326-6-20.

BACKGROUND: Several lines of evidence indicate that memory loss represents a synaptic failure caused by soluble amyloid β (Aβ) oligomers. However, the pathological relevance of Aβ oligomers (AβOs) as the trigger of synaptic or neuronal degeneration, and the possible...

Cite
Takamura A, Okamoto Y, Kawarabayashi T, et al. Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse. Mol Neurodegener. 2011;6(1):20doi: 10.1186/1750-1326-6-20.
Takamura, A., Okamoto, Y., Kawarabayashi, T., Yokoseki, T., Shibata, M., Mouri, A., Nabeshima, T., Sun, H., Abe, K., Urisu, T., Yamamoto, N., Shoji, M., Yanagisawa, K., Michikawa, M., & Matsubara, E. (2011). Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse. Molecular neurodegeneration, 6(1), 20. https://doi.org/10.1186/1750-1326-6-20
Takamura, Ayumi, et al. "Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse." Molecular neurodegeneration vol. 6,1 (2011): 20. doi: https://doi.org/10.1186/1750-1326-6-20
Takamura A, Okamoto Y, Kawarabayashi T, Yokoseki T, Shibata M, Mouri A, Nabeshima T, Sun H, Abe K, Urisu T, Yamamoto N, Shoji M, Yanagisawa K, Michikawa M, Matsubara E. Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse. Mol Neurodegener. 2011 Mar 06;6(1):20. doi: 10.1186/1750-1326-6-20. PMID: 21375782; PMCID: PMC3061944.
Copy Download .nbib Format: NLM
First-principles study on ferroelectricity at PbTiO3 surface steps.

Journal of physics. Condensed matter : an Institute of Physics journal

Shimada T, Tomoda S, Kitamura T.
PMID: 21403300
J Phys Condens Matter. 2010 Sep 08;22(35):355901. doi: 10.1088/0953-8984/22/35/355901. Epub 2010 Aug 13.

We performed ab initio density functional theory calculations to investigate ferroelectricity at PbTiO(3) surface steps consisting of (100) and (001) surfaces with the polar axis in the [010] direction. Ferroelectricity was enhanced at PbO-terminated surface steps due to enhanced...

Cite
Shimada T, Tomoda S, Kitamura T. First-principles study on ferroelectricity at PbTiO3 surface steps. J Phys Condens Matter. 2010;22(35):355901doi: 10.1088/0953-8984/22/35/355901.
Shimada, T., Tomoda, S., & Kitamura, T. (2010). First-principles study on ferroelectricity at PbTiO3 surface steps. Journal of physics. Condensed matter : an Institute of Physics journal, 22(35), 355901. https://doi.org/10.1088/0953-8984/22/35/355901
Shimada, T, et al. "First-principles study on ferroelectricity at PbTiO3 surface steps." Journal of physics. Condensed matter : an Institute of Physics journal vol. 22,35 (2010): 355901. doi: https://doi.org/10.1088/0953-8984/22/35/355901
Shimada T, Tomoda S, Kitamura T. First-principles study on ferroelectricity at PbTiO3 surface steps. J Phys Condens Matter. 2010 Sep 08;22(35):355901. doi: 10.1088/0953-8984/22/35/355901. Epub 2010 Aug 13. PMID: 21403300.
Copy Download .nbib Format: NLM
Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity.

Toxicological research

Shimada T.
PMID: 28443179
Toxicol Res. 2017 Apr;33(2):79-96. doi: 10.5487/TR.2017.33.2.079. Epub 2017 Apr 15.

A variety of xenobiotic chemicals, such as polycyclic aromatic hydrocarbons (PAHs), aryl- and heterocyclic amines and tobacco related nitrosamines, are ubiquitous environmental carcinogens and are required to be activated to chemically reactive metabolites by xenobiotic-metabolizing enzymes, including cytochrome P450...

Cite
Shimada T. Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity. Toxicol Res. 2017;33(2):79-96doi: 10.5487/TR.2017.33.2.079.
Shimada, T. (2017). Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity. Toxicological research, 33(2), 79-96. https://doi.org/10.5487/TR.2017.33.2.079
Shimada, Tsutomu. "Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity." Toxicological research vol. 33,2 (2017): 79-96. doi: https://doi.org/10.5487/TR.2017.33.2.079
Shimada T. Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity. Toxicol Res. 2017 Apr;33(2):79-96. doi: 10.5487/TR.2017.33.2.079. Epub 2017 Apr 15. PMID: 28443179; PMCID: PMC5402866.
Copy Download .nbib Format: NLM
Complementary and synergistic therapeutic effects of compounds found in Kampo medicine: analysis of daikenchuto.

Frontiers in pharmacology

Kono T, Shimada M, Yamamoto M, Kaneko A, Oomiya Y, Kubota K, Kase Y, Lee K, Uezono Y.
PMID: 26300774
Front Pharmacol. 2015 Aug 04;6:159. doi: 10.3389/fphar.2015.00159. eCollection 2015.

Herbal medicines have been used in Japan for more than 1500 years and traditional Japanese medicines (Kampo medicines) are now fully integrated into the modern healthcare system. In total, 148 Kampo formulae are officially approved as prescription drugs and...

Cite
Kono T, Shimada M, Yamamoto M, et al. Complementary and synergistic therapeutic effects of compounds found in Kampo medicine: analysis of daikenchuto. Front Pharmacol. 2015;6:159doi: 10.3389/fphar.2015.00159.
Kono, T., Shimada, M., Yamamoto, M., Kaneko, A., Oomiya, Y., Kubota, K., Kase, Y., Lee, K., & Uezono, Y. (2015). Complementary and synergistic therapeutic effects of compounds found in Kampo medicine: analysis of daikenchuto. Frontiers in pharmacology, 6159. https://doi.org/10.3389/fphar.2015.00159
Kono, Toru, et al. "Complementary and synergistic therapeutic effects of compounds found in Kampo medicine: analysis of daikenchuto." Frontiers in pharmacology vol. 6 (2015): 159. doi: https://doi.org/10.3389/fphar.2015.00159
Kono T, Shimada M, Yamamoto M, Kaneko A, Oomiya Y, Kubota K, Kase Y, Lee K, Uezono Y. Complementary and synergistic therapeutic effects of compounds found in Kampo medicine: analysis of daikenchuto. Front Pharmacol. 2015 Aug 04;6:159. doi: 10.3389/fphar.2015.00159. eCollection 2015. PMID: 26300774; PMCID: PMC4523940.
Copy Download .nbib Format: NLM
Alteration of regional brain oxygen saturation (rSO.

Journal of anesthesia

Isa Y, Saito S, Asakura M, Yoshikawa D, Shimada H, Morita T, Kunimoto F, Goto F.
PMID: 28921253
J Anesth. 1998 Jun;12(2):106-108. doi: 10.1007/BF02480782.

No abstract available.

Cite
Isa Y, Saito S, Asakura M, et al. Alteration of regional brain oxygen saturation (rSO. J Anesth. 1998;12(2):106-108doi: 10.1007/BF02480782.
Isa, Y., Saito, S., Asakura, M., Yoshikawa, D., Shimada, H., Morita, T., Kunimoto, F., & Goto, F. (1998). Alteration of regional brain oxygen saturation (rSO. Journal of anesthesia, 12(2), 106-108. https://doi.org/10.1007/BF02480782
Isa, Yukitaka, et al. "Alteration of regional brain oxygen saturation (rSO." Journal of anesthesia vol. 12,2 (1998): 106-108. doi: https://doi.org/10.1007/BF02480782
Isa Y, Saito S, Asakura M, Yoshikawa D, Shimada H, Morita T, Kunimoto F, Goto F. Alteration of regional brain oxygen saturation (rSO. J Anesth. 1998 Jun;12(2):106-108. doi: 10.1007/BF02480782. PMID: 28921253.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 3278 entries